NCT04360928

Brief Summary

This study will evaluate the efficacy of the Graymont X ERIS Knee Splint brace in the postoperative period of ACL reconstruction to improve range of motion, specifically the achievement of terminal extension and time-to-achievement compared to the standard hinged knee brace. This will be directly measured with goniometric angle and heel-height measurements relative to the contralateral side. Other metrics will include standard, validated patient reported outcomes and requirements for additional interventions to treat extension deficits including, but not limited to, additional therapy, intraarticular injections, oral corticosteroids, manipulation under anesthesia, or arthroscopic arthrolysis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
3.3 years until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2025

Completed
Last Updated

January 9, 2025

Status Verified

January 1, 2025

Enrollment Period

1.4 years

First QC Date

March 6, 2020

Last Update Submit

January 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Time to full symmetric extension

    Time-to-achievement of full symmetric extension relative to the non-surgical knee

    Up to 6 months postoperatively

  • Range of motion

    Includes heel-height measurements

    6 months postoperatively

Study Arms (2)

Graymont X ERIS Knee Splint Degree Splinting Group

EXPERIMENTAL

These patients will be randomized to receive the Graymont X ERIS Knee Splint. Patients will follow the same standardized postoperative rehabilitation protocol.

Device: Graymont X ERIS Knee Splint

Standard Hinged Knee Brace

SHAM COMPARATOR

These patients will be randomized to receive a standard hinged knee brace. Patients will follow the same standardized postoperative rehabilitation protocol.

Device: Standard Hinge Knee Brace

Interventions

Specific type of splint which utilizes an inflatable air pocket on the posterior aspect of the leg to provide a combination of bracing and splinting in full extension in the immediate postoperative period.

Graymont X ERIS Knee Splint Degree Splinting Group

Standard knee brace used postoperatively after ACL reconstruction.

Standard Hinged Knee Brace

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Primary ACL Reconstruction
  • Clinical and radiographic examination (MRI), performed as standard of care prior to study enrollment, consistent with an acute full thickness ACL tear and surgical consent for ACL reconstruction with a patellar tendon autograft
  • Written and informed consent for study participation

You may not qualify if:

  • Patients younger than 18 or older than 40 years of age
  • Revision surgery or prior history of knee surgery
  • Concomitant ligamentous, meniscal, or cartilage injury that would alter postoperative weight bearing status or rehabilitation protocol
  • Inability to comply with the proposed follow-up clinic visits
  • Patients lacking decisional capacity
  • Pregnant or breast-feeding women
  • Worker's compensation patients
  • Any clinically significant finding that would place the patient at health risk, impact the study, or affect the completion of the study
  • Any psychiatric illness that would prevent comprehension of the details and nature of the study and interfere with follow-up clinic visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2020

First Posted

April 24, 2020

Study Start

August 1, 2023

Primary Completion

January 1, 2025

Study Completion

January 6, 2025

Last Updated

January 9, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

No plan to share IPD to other researchers.

Locations